Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 950

1.

Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.

Valeti US, Nishimura RA, Holmes DR, Araoz PA, Glockner JF, Breen JF, Ommen SR, Gersh BJ, Tajik AJ, Rihal CS, Schaff HV, Maron BJ.

J Am Coll Cardiol. 2007 Jan 23;49(3):350-7.

PMID:
17239717
2.

Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue.

Talreja DR, Nishimura RA, Edwards WD, Valeti US, Ommen SR, Tajik AJ, Dearani JA, Schaff HV, Holmes DR Jr.

J Am Coll Cardiol. 2004 Dec 21;44(12):2329-32.

PMID:
15607394
3.

Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes.

Firoozi S, Elliott PM, Sharma S, Murday A, Brecker SJ, Hamid MS, Sachdev B, Thaman R, McKenna WJ.

Eur Heart J. 2002 Oct;23(20):1617-24.

PMID:
12323162
4.

Comparison of left ventricular diastolic function in obstructive hypertrophic cardiomyopathy in patients undergoing percutaneous septal alcohol ablation versus surgical myotomy/myectomy.

Sitges M, Shiota T, Lever HM, Qin JX, Bauer F, Drinko JK, Agler DA, Martin MG, Greenberg NL, Smedira NG, Lytle BW, Tuzcu EM, Garcia MJ, Thomas JD.

Am J Cardiol. 2003 Apr 1;91(7):817-21.

PMID:
12667567
5.

Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.

Seggewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt HK, Strick S.

J Am Coll Cardiol. 1998 Feb;31(2):252-8.

PMID:
9462563
6.

Myectomy or alcohol septal ablation surgery and percutaneous intervention go another round.

Heldman AW, Wu KC, Abraham TP, Cameron DE.

J Am Coll Cardiol. 2007 Jan 23;49(3):358-60. No abstract available.

PMID:
17239718
7.

Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a review of the literature.

Veselka J.

Med Sci Monit. 2007 Apr;13(4):RA62-8. Review.

PMID:
17392660
8.

Does myectomy convey survival benefit in hypertrophic cardiomyopathy?

Woo A, Rakowski H.

Heart Fail Clin. 2007 Jul;3(3):275-88. Review.

PMID:
17723936
9.

Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy.

Sorajja P, Valeti U, Nishimura RA, Ommen SR, Rihal CS, Gersh BJ, Hodge DO, Schaff HV, Holmes DR Jr.

Circulation. 2008 Jul 8;118(2):131-9. doi: 10.1161/CIRCULATIONAHA.107.738740.

PMID:
18591440
10.
11.

Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experience.

Kuhn H, Lawrenz T, Lieder F, Leuner C, Strunk-Mueller C, Obergassel L, Bartelsmeier M, Stellbrink C.

Clin Res Cardiol. 2008 Apr;97(4):234-43.

PMID:
18071624
12.

Long-lasting improvement after septal myectomy for hypertrophic obstructive cardiomyopathy.

Merrill WH, Friesinger GC, Graham TP Jr, Byrd BF 3rd, Drinkwater DC Jr, Christian KG, Bender HW Jr.

Ann Thorac Surg. 2000 Jun;69(6):1732-5; discussion 1735-6.

PMID:
10892916
13.

Percutaneous septal ablation after unsuccessful surgical myectomy for patients with hypertrophic obstructive cardiomyopathy.

Faber L, Welge D, Hering D, Butz T, Oldenburg O, Seggewiss H, Horstkotte D.

Clin Res Cardiol. 2008 Dec;97(12):899-904. doi: 10.1007/s00392-008-0707-0.

PMID:
18777001
14.

Outcome of surgical myectomy after unsuccessful alcohol septal ablation for the treatment of patients with hypertrophic obstructive cardiomyopathy.

Nagueh SF, Buergler JM, Quinones MA, Spencer WH 3rd, Lawrie GM.

J Am Coll Cardiol. 2007 Aug 21;50(8):795-8.

PMID:
17707185
15.

Mechanisms for recurrent left ventricular outflow tract obstruction after septal myectomy for obstructive hypertrophic cardiomyopathy.

Minakata K, Dearani JA, Schaff HV, O'Leary PW, Ommen SR, Danielson GK.

Ann Thorac Surg. 2005 Sep;80(3):851-6.

PMID:
16122442
16.

Controversies in cardiovascular medicine. Benefits of surgery in obstructive hypertrophic cardiomyopathy: bring septal myectomy back for European patients.

Maron BJ, Yacoub M, Dearani JA.

Eur Heart J. 2011 May;32(9):1055-8. doi: 10.1093/eurheartj/ehr006. Review.

PMID:
21324934
17.

Selection of hypertrophic cardiomyopathy patients for myectomy or alcohol septal ablation.

Lever HM.

Anadolu Kardiyol Derg. 2006 Dec;6 Suppl 2:27-30. Review.

PMID:
17162266
18.

Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Will there ever be a randomized trial?

Olivotto I, Ommen SR, Maron MS, Cecchi F, Maron BJ.

J Am Coll Cardiol. 2007 Aug 28;50(9):831-4. Review.

PMID:
17719467
19.

Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis.

Alam M, Dokainish H, Lakkis NM.

Eur Heart J. 2009 May;30(9):1080-7. doi: 10.1093/eurheartj/ehp016.

PMID:
19233857
20.

Percutaneous versus surgical treatment for patients with hypertrophic obstructive cardiomyopathy and enlarged anterior mitral valve leaflets.

van der Lee C, ten Cate FJ, Geleijnse ML, Kofflard MJ, Pedone C, van Herwerden LA, Biagini E, Vletter WB, Serruys PW.

Circulation. 2005 Jul 26;112(4):482-8. Erratum in: Circulation. 2006 Jan 24;113(3):e46.

PMID:
16027255
Items per page

Supplemental Content

Support Center